trending Market Intelligence /marketintelligence/en/news-insights/trending/MYik_p6_jPrXUYH8cHcmJg2 content esgSubNav
In This List

G Medical Innovations files for $17M Nasdaq IPO

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


G Medical Innovations files for $17M Nasdaq IPO

G Medical Innovations Holdings Ltd. is looking to raise up to $17.3 million in an IPO of its American depositary shares.

The mobile and e-health company applied to list its ADSs on the Nasdaq Capital Market under the GMVD symbol.

G Medical noted that its shares will remain listed on the Australian Securities Exchange and will be dual listed on Nasdaq following U.S. IPO completion.

H.C. Wainwright & Co. LLC is acting as underwriter and sole running manager in the U.S. offering.

Cayman Islands-based G Medical is an early-stage commercial healthcare company that develops mobile and e-health solutions as well as monitoring platforms for patients with cardiovascular disease, pulmonary disease and diabetes.